These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 7533370)

  • 1. Common and sequential overexpression patterns of T-helper cytokines during acute (cellular) rejection, and correlation of proinflammatory cytokine expression with chronic (ductopenic) rejection of human liver allografts: a study under cyclosporine, FK 506, and quadruple BT 563 immunosuppression.
    Gaweco AS; Otto G; Otto HF; Meuer S; Geisse T; Hofmann WJ
    Transplant Proc; 1995 Feb; 27(1):1152-4. PubMed ID: 7533370
    [No Abstract]   [Full Text] [Related]  

  • 2. Distinct intragraft cytokine gene expression patterns during acute hepatic rejection under cyclosporine versus FK 506 primary immunosuppression.
    Gaweco AS; Otto G; Otto HF; Geisse T; Hofmann WJ
    Transplant Proc; 1994 Dec; 26(6):3111-3. PubMed ID: 7527948
    [No Abstract]   [Full Text] [Related]  

  • 3. High expression of TIAF-1 in chronic kidney and liver allograft rejection and in activated T-helper cells.
    van der Leij J; van den Berg A; Albrecht EW; Blokzijl T; Roozendaal R; Gouw AS; de Jong KP; Stegeman CA; van Goor H; Chang NS; Poppema S
    Transplantation; 2003 Jun; 75(12):2076-82. PubMed ID: 12829915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intragraft cytokine and cytotoxic T lymphocyte (CTL) specific protein expression as predictors of rat small intestine transplant rejection.
    McDiarmid SV; Farmer DG; Kuniyoshi JS; Robert M; Khadavi A; Shaked A; Busuttil RW
    Transplant Proc; 1994 Jun; 26(3):1520-1. PubMed ID: 8030018
    [No Abstract]   [Full Text] [Related]  

  • 5. Th1 and Th2 cytokine gene expression in human renal allografts.
    Joseph JV; Guy SP; Brenchley PE; Parrott NR; Short CD; Johnson RW; Hutchinson IV
    Transplant Proc; 1995 Feb; 27(1):915-6. PubMed ID: 7879228
    [No Abstract]   [Full Text] [Related]  

  • 6. Quadruple induction immunosuppression after liver transplantation with IL-2 receptor antibody (BT 563) is equally effective and better tolerated than ATG induction therapy.
    Neuhaus B; Keck H; Bechstein WO; Blumhardt G; Langrehr JM; Wiens M; Lemmens HP; Lohmann R; Schlag H; Thalmann U
    Transplant Proc; 1993 Feb; 25(1 Pt 1):587-9. PubMed ID: 8438426
    [No Abstract]   [Full Text] [Related]  

  • 7. Experimental and clinical allogeneic heart transplant rejection: correlations between histology and immune reactivity detected by cytokine messenger RNA.
    Normann SJ; Peck AB; Staples ED; Salomon DR; Mills RM
    J Heart Lung Transplant; 1996 Aug; 15(8):778-89. PubMed ID: 8878760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytokine gene polymorphisms and acute human liver graft rejection.
    Warlé MC; Farhan A; Metselaar HJ; Hop WC; Perrey C; Zondervan PE; Kap M; de Rave S; Kwekkeboom J; Ijzermans JN; Tilanus HW; Pravica V; Hutchinson IV; Bouma GJ
    Liver Transpl; 2002 Jul; 8(7):603-11. PubMed ID: 12089714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of cytokine expression in an animal model of acute liver allograft rejection.
    Egawa H; Martinez OM; Quinn MB; So S; Esquivel CO; Krams SM
    Transplant Proc; 1995 Feb; 27(1):505-6. PubMed ID: 7879079
    [No Abstract]   [Full Text] [Related]  

  • 10. Distinct patterns of Th2 cytokine production during immune activation in pediatric liver allograft recipients.
    Lang T; Krams SM; Villanueva JC; Cox K; So S; Esquivel C; Martinez OM
    Transplant Proc; 1995 Feb; 27(1):1146-7. PubMed ID: 7533367
    [No Abstract]   [Full Text] [Related]  

  • 11. Intragraft monitoring of rejection after prophylactic treatment with monoclonal anti-interleukin-2 receptor antibody (BT563) in heart transplant recipients.
    van Gelder T; Mulder AH; Balk AH; Mochtar B; Hesse CJ; Baan CC; Vaessen LM; Weimar W
    J Heart Lung Transplant; 1995; 14(2):346-50. PubMed ID: 7779855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A short course of cyclosporine immunosuppression inhibits rejection but not tolerance of rat liver allografts.
    Huang WH; Yan Y; De Boer B; Bishop GA; House AK
    Transplantation; 2003 Feb; 75(3):368-74. PubMed ID: 12589161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Semiquantitative measurement of cytokine messenger RNA in endomyocardium and peripheral blood mononuclear cells from human heart transplant recipients.
    Lagoo AS; George JF; Naftel DC; Griffin AK; Kirklin JK; Lagoo-Deenadayalan S; Hardy KJ; Savunen T; McGiffin DC
    J Heart Lung Transplant; 1996 Feb; 15(2):206-17. PubMed ID: 8672525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-interleukin-2 receptor (IL-2R) antibody against rejection of organ grafts.
    Kupiec-Weglinski JW; Padberg W; Uhteg LC; Towpik E; Lord RH; Ma L; Diamantstein T; Strom TB; Tilney NL
    Transplant Proc; 1987 Feb; 19(1 Pt 1):591-3. PubMed ID: 2978926
    [No Abstract]   [Full Text] [Related]  

  • 15. Identification of cytokine protein expression in human liver allograft rejection: methods development and expression of IL-1 beta, IL-6, IFN-gamma, and basic fibroblast growth factor.
    Bishop GA; Matsumoto Y; McCaughan GW; Kenney JS
    Transplant Proc; 1992 Oct; 24(5):2310-2. PubMed ID: 1413073
    [No Abstract]   [Full Text] [Related]  

  • 16. Recurrent rejection following FK 506 rescue therapy for acute hepatic allograft rejection.
    Woodle ES; So S; Jendrisak MD; Perdrizet GA; White HM; Marsh JW
    Transplant Proc; 1993 Apr; 25(2):1988-9. PubMed ID: 7682358
    [No Abstract]   [Full Text] [Related]  

  • 17. Use of FK 506 for the prevention of recurrent allograft rejection after successful conversion from cyclosporine for refractory rejection. US Multicenter FK 506 Liver Study Group.
    Klintmalm GB; Goldstein R; Gonwa T; Wiesner RH; Krom RA; Shaw BW; Stratta R; Ascher NL; Roberts JW; Lake J
    Transplant Proc; 1993 Feb; 25(1 Pt 1):635-7. PubMed ID: 7679826
    [No Abstract]   [Full Text] [Related]  

  • 18. Enhanced expression of cytokine-induced neutrophil chemoattractant in rat hepatic allografts during acute rejection.
    Yamaguchi Y; Ichiguchi O; Matsumura F; Akizuki E; Matsuda T; Okabe K; Yamada S; Liang J; Mori K; Ogawa M
    Hepatology; 1997 Dec; 26(6):1546-52. PubMed ID: 9397996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-12: a possible cytotoxic T-lymphocyte differentiation factor in allograft recipients.
    Gish RG; Krams SM; Martinez OM
    Transplant Proc; 1995 Feb; 27(1):459-60. PubMed ID: 7879061
    [No Abstract]   [Full Text] [Related]  

  • 20. Influence of the anti-CD25 monoclonal antibody BT563 on clinical and biological rejection after orthotopic liver transplantation.
    Otto G; Hofmann WJ; Gaweco AS; Seelos R; Herfarth C; Meuer S
    Transplant Proc; 1996 Dec; 28(6):3210-1. PubMed ID: 8962244
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.